Pharmadrug Inc.
PHRX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.80K | 37.60K | 47.50K | 295.40K | 773.90K |
| Depreciation & Amortization | 36.00K | 36.10K | 36.20K | 36.70K | 47.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.60K | 148.20K | 135.40K | 432.00K | 892.60K |
| Operating Income | -130.60K | -148.20K | -135.40K | -432.00K | -892.60K |
| Income Before Tax | -211.20K | -280.60K | -324.50K | -644.30K | -10.47M |
| Income Tax Expenses | -- | -- | -- | -- | -742.60K |
| Earnings from Continuing Operations | -0.21 | -0.28 | -0.32 | -0.64 | -9.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 84.90K | 84.80K | 85.50K | 106.40K | 94.20K |
| Net Income | -126.30K | -195.90K | -239.20K | -538.00K | -9.63M |
| EBIT | -130.60K | -148.20K | -135.40K | -432.00K | -892.60K |
| EBITDA | -94.60K | -112.10K | -99.20K | -395.30K | -860.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.13 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.13 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 432.00M | 427.91M | 420.06M | 407.20M | 372.98M |
| Average Diluted Shares Outstanding | 432.00M | 427.91M | 420.06M | 407.20M | 372.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |